IONQ Inc vs Regeneron Pharmaceuticals Inc — how do they compare? IONQ Inc trades at $44.05 (market cap $17.60B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 4.7× IONQ Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while IONQ Inc pays none. Which is the better fit depends on your goals.
| IONQ | REGN | |
|---|---|---|
Market Cap | $17.60B | $82.06B |
Sector | Technology | Health |
52-Week High | $82.09 | $812.27 |
52-Week Low | $26.59 | $555.51 |
Enterprise Value | $15.53B | $76.77B |
Dividend Yield | — | 0.47% |
Trailing returns across standard periods
Latest headlines on both assets
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →